Why do we not have an HIV vaccine and how can we make one? - PubMed (original) (raw)

. 1998 May;4(5 Suppl):495-8.

doi: 10.1038/nm0598supp-495.

Affiliations

• PMID: 9585194
• DOI: 10.1038/nm0598supp-495

Why do we not have an HIV vaccine and how can we make one?

D R Burton et al. Nat Med. 1998 May.

No abstract available

PubMed Disclaimer

Comment in

• Vaccine reactions.
  Mascola JR, McNeil JG, Birx DL. Mascola JR, et al. Nat Med. 1998 Jul;4(7):746. doi: 10.1038/nm0798-746a. Nat Med. 1998. PMID: 9662343 No abstract available.
• Vaccine reactions.
  Francis DP, Nowinski RC. Francis DP, et al. Nat Med. 1998 Jul;4(7):746. doi: 10.1038/nm0798-746c. Nat Med. 1998. PMID: 9662345 No abstract available.

Similar articles

• HIV vaccines--where are we going?
  Heilman CA, Baltimore D. Heilman CA, et al. Nat Med. 1998 May;4(5 Suppl):532-4. doi: 10.1038/nm0598supp-532. Nat Med. 1998. PMID: 9585205 Review. No abstract available.
• Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
  Enose Y, Kita M, Yamamoto T, Suzuki H, Miyake A, Horiuchi R, Ibuki K, Kaneyasu K, Kuwata T, Takahashi E, Sakai K, Shinohara K, Miura T, Hayami M. Enose Y, et al. Arch Virol. 2004 Sep;149(9):1705-20. doi: 10.1007/s00705-004-0333-8. Arch Virol. 2004. PMID: 15593414
• SIV vaccine for AIDS.
  Farthing CF, Sullivan JL. Farthing CF, et al. Science. 1998 Jan 2;279(5347):14-5. doi: 10.1126/science.279.5347.10i. Science. 1998. PMID: 9441400 No abstract available.
• AIDS 1995. Vaccines and immunology: overview.
  Montelaro RC, Wigzell H. Montelaro RC, et al. AIDS. 1995;9 Suppl A:S111-2. AIDS. 1995. PMID: 8819577 No abstract available.
• [HIV vaccine].
  Matano T. Matano T. Nihon Rinsho. 2005 May;63 Suppl 5:659-65. Nihon Rinsho. 2005. PMID: 15954426 Review. Japanese. No abstract available.

Cited by

• Applications of molecular networks in biomedicine.
  Chagoyen M, Ranea JAG, Pazos F. Chagoyen M, et al. Biol Methods Protoc. 2019 Sep 23;4(1):bpz012. doi: 10.1093/biomethods/bpz012. eCollection 2019. Biol Methods Protoc. 2019. PMID: 32395629 Free PMC article. Review.
• Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.
  Florese RH, Demberg T, Xiao P, Kuller L, Larsen K, Summers LE, Venzon D, Cafaro A, Ensoli B, Robert-Guroff M. Florese RH, et al. J Immunol. 2009 Mar 15;182(6):3718-27. doi: 10.4049/jimmunol.0803115. J Immunol. 2009. PMID: 19265150 Free PMC article.
• Immunogenicity of the outer domain of a HIV-1 clade C gp120.
  Chen H, Xu X, Jones IM. Chen H, et al. Retrovirology. 2007 May 17;4:33. doi: 10.1186/1742-4690-4-33. Retrovirology. 2007. PMID: 17509143 Free PMC article.
• Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.
  Horton H, Havenar-Daughton C, Lee D, Moore E, Cao J, McNevin J, Andrus T, Zhu H, Rubin A, Zhu T, Celum C, McElrath MJ. Horton H, et al. J Virol. 2006 Oct;80(19):9779-88. doi: 10.1128/JVI.00794-06. J Virol. 2006. PMID: 16973582 Free PMC article.
• Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1.
  Poon B, Safrit JT, McClure H, Kitchen C, Hsu JF, Gudeman V, Petropoulos C, Wrin T, Chen IS, Grovit-Ferbas K. Poon B, et al. J Virol. 2005 Apr;79(8):4927-35. doi: 10.1128/JVI.79.8.4927-4935.2005. J Virol. 2005. PMID: 15795278 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations